Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall

被引:37
作者
Grabnar, I [1 ]
Bogataj, M [1 ]
Mrhar, A [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
chitosan; polycarbophil; permeation enhancement; mucoadhesion; urinary bladder; intravesical instillation;
D O I
10.1016/S0378-5173(03)00074-7
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Influence of dispersions of mucoadhesive polymers chitosan and polycarbophil on permeability properties of urinary bladder was investigated in vitro on isolated porcine urinary bladder. Pipemidic acid as a model hydrophilic drug was used. Its distribution in the bladder wall was determined from actual tissue concentrations by a method based on sectioning of frozen tissue and extraction of tissue slices. Pipemidic acid tissue concentration versus tissue depth profiles were evaluated by a diffusion model assuming constant diffusion coefficient. Increase in bladder wall permeability was observed in the presence of both polymers. Apparent permeability (mean +/- S.D.) of urinary bladder wall was increased 2.7 +/- 2.9 and 2.8 +/- 2.0 times for chitosan, and 2.3 +/- 2.0 and 4.3 +/- 4.2 times for polycarbophil at 0.5 and 1.0%, w/v polymer concentration, respectively. This increase is a consequence of the increased permeability of urothelium. These findings support investigations on application of chitosan and polycarbophil in development of mucoadhesive intravesical drug delivery systems. Experimental model may be applied to evaluate the results of experiments with drugs used in intravesical therapy. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 22 条
[1]
Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa [J].
Bogataj, M ;
Mrhar, A ;
Korosec, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 177 (02) :211-220
[2]
BURJAK M, 2000, P INT S CONTR REL BI, V27, P798
[3]
PERMEABILITY PROPERTIES OF THE MAMMALIAN BLADDER APICAL MEMBRANE [J].
CHANG, A ;
HAMMOND, TG ;
SUN, TT ;
ZEIDEL, ML .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1994, 267 (05) :C1483-C1492
[4]
Crank J., 1985, MATH DIFFUSION
[5]
THE DEVELOPMENT OF LIPOSOMES CONTAINING INTERFERON-ALPHA FOR THE INTRAVESICAL THERAPY OF HUMAN SUPERFICIAL BLADDER-CANCER [J].
FRANGOS, DN ;
KILLION, JJ ;
FAN, D ;
FISHBECK, R ;
VONESCHENBACH, AC ;
FIDLER, IJ .
JOURNAL OF UROLOGY, 1990, 143 (06) :1252-1256
[6]
Getliffe KA, 1996, J ADV NURS, V23, P548
[7]
Current management of funguria [J].
Gubbins, PO ;
McConnell, SA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (19) :1929-1935
[8]
Intravesical drug delivery - Pharmacokinetic and clinical considerations [J].
Highley, MS ;
van Oosterom, AT ;
Maes, RA ;
De Bruijn, EA .
CLINICAL PHARMACOKINETICS, 1999, 37 (01) :59-73
[9]
IDENTIFICATION OF PROTEOGLYCANS PRESENT AT HIGH-DENSITY ON BOVINE AND HUMAN BLADDER LUMINAL SURFACE [J].
HURST, RE ;
ZEBROWSKI, R .
JOURNAL OF UROLOGY, 1994, 152 (05) :1641-1645
[10]
BINDING OF LIPOSOMES TO HUMAN BLADDER-TUMOR EPITHELIAL-CELL LINES - IMPLICATIONS FOR AN INTRAVESICAL DRUG DELIVERY SYSTEM FOR THE TREATMENT OF BLADDER-CANCER [J].
JOHNSON, JW ;
NAYAR, R ;
KILLION, JJ ;
VONESCHENBACH, AC ;
FIDLER, IJ .
SELECTIVE CANCER THERAPEUTICS, 1989, 5 (04) :147-155